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Background: In some studies, high intake of dietary fibre has been associated with a lower risk of colorectal
cancer. The present study aimed to compare physiological effects of three legume kernel fibres and citrus fibre on
blood lipids (primary outcome: LDL cholesterol) and colonic health.
Methods: Ninety-two subjects were recruited for the double-blind, controlled crossover trial. Seventy-eight
participants were randomly divided into three groups. Following run-in, half the volunteers from each group
consumed 25 g/d of a legume fibre, comprising blue lupin fibre, white lupin fibre, and soya fibre for two weeks.
The other half received the same amount of citrus fibre (active comparator). The intervention was crossed within
each group after two weeks wash-out. At the end of run-in and intervention, a quantitative faeces collection took
place and fasting blood samples were drawn. Repeated measures ANOVA with the general linear model were
applied to evaluate changes following interventions.
Results: Seventy-six subjects completed the study. Dietary fibre intake during all interventions was approximately
twice the fibre intake at run-in. The lupin fibre supplementations increased daily faecal dry matter and faecal weight
compared to run-in, representing an increase of 1.76 g faeces/g additional dietary fibre contributed by blue lupin
and of 1.64 g faeces/g by white lupin, respectively. Both lupin interventions led to a significantly enhanced
formation of short-chain fatty acids, and blue lupin fibre to a decrease in faecal pH compared to run-in (0.27 units,
P < 0.01). Further, blue lupin increased primary bile acids-excretion (P = 0.02). All legume fibres reduced faecal
concentrations of total and secondary bile acids (blue lupin: 16%; white lupin: 24%; soya: 16%). Blood lipids were
not influenced by any intervention. No serious adverse effects were observed.
Conclusions: The tested fibre preparations do not affect lipid metabolism through bile acid-binding in
normocholesterolaemic subjects. However, particularly blue lupin kernel fibre improve colonic function and have
beneficial effects on putative risk factors for colorectal cancer such as faecal mass, transit time, SCFA, faecal pH, and
secondary bile acid concentration. Therefore, enhancing dietary fibre intake through blue lupin up to about 50 g/d
can be recommended.
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Colorectal cancer is the second most common cause of
death from cancer, with 447,000 new cases diagnosed in
Europe in 2012 [1]. Nutritional factors are thought to be
responsible for an estimated 50% of the incidence [2]. A
high intake of dietary fibre has been associated in some,
but not all, studies with a lower risk of colorectal cancer.
Therefore, supplementation with dietary fibre is of spe-
cial importance as far too little fibre is generally con-
sumed. Current guidelines from the European Food
Safety Authority recommend an intake of 25 g of dietary
fibre per day (2 g/MJ) for adults [3]. Many epidemiological
studies support Burkitt’s hypothesis that increased dietary
fibre intake leads to a reduced risk of colorectal cancer
[4-6], while others revealed contradictory effects [7,8].
Case–control studies have generally shown a protective
association [9], whereas results from cohort studies have
not been consistent [4,8,10-14]. The inconsistencies of
study findings may in part be explained by heterogeneity
regarding the chemical and physicochemical properties of
dietary fibre and the source of fibre [6,7,15,16]. However,
the World Cancer Research Fund (WCRF), in conjunction
with the American Institute for Cancer Research (AICR),
released an updated meta-analysis of 25 prospective stu-
dies in 2011, which concludes that 10 g/d of total dietary
fibre decreases the relative risk of colorectal cancer by
10% [2,17].
Legume seeds are a valuable plant source of dietary
fibre. Besides favourable technofunctional properties,
legume kernel fibres offer several physiological benefits
[18-21]. There is evidence indicating that consumption
of legume kernel fibre, e.g. soya and lupin kernel fibre,
may have a preventive impact on colorectal cancer
[18,19]. Aune et al. reported a 38% reduction in relative
risk for each 10 g/d intake of legume fibre [16].
Several plausible mechanisms for the protective effects of
dietary fibre on colorectal cancer have been hypothesised.
These include direct effects on the composition of the gut
and on bowel habits together with indirect effects such as
systemic changes in insulin and hormonal exposures
[4,7,16,22,23]. In particular, dietary fibre benefits colonic
health by decreasing the toxicity of colonic content. Fibre,
which is not soluble in water, enhances faecal bulk by its
ability to bind water [24]. The increased gut content
promotes stimulation of intestinal peristalsis and reduc-
tion of transit time which leads to a decreased contact of
enterocytes with harmful substances, particularly carcino-
gens [15,24]. Water-soluble fibre is known to have less
effect on faecal bulking because they are largely
fermented by resident bacteria in the colon. The fer-
mentation process promotes bacterial growth and pro-
duces short-chain fatty acids (SCFA) in the colon [15].
SCFA are an important energy source for colonocytes.
Moreover, n-butyrate is able to reduce the risk ofmalignant changes through regulation of colonocyte dif-
ferentiation [25,26]. Further, SCFA lower the pH value
of the colon resulting in decreased formation of carcin-
ogens from bacterially degraded bile acids and choles-
terol, and restricted growth of potentially pathogenic
bacteria [24,25,27]. Dietary fibre is also thought to
modulate faecal concentration, distribution and excre-
tion of bile acids due to bile acid binding, increased fae-
cal bulk and altered pH value. Bile acids, in particular,
secondary bile acids are putative risk factors for colorec-
tal cancer [28,29].
Moreover, the ability of fibre, in particular the water-
soluble fraction, to bind bile acids possibly leads to an
interruption of the enterohepatic circulation resulting in
lower LDL cholesterol concentrations in blood [30].
Thus, this double-blind crossover intervention trial was
designed to compare broad physiological effects of specific
types of legume fibre with citrus fibre. In particular, the
study aimed to evaluate the short-term effects of three
isolated legume kernel fibre preparations on blood lipids
(primary outcome: LDL cholesterol), markers of intestinal
health, bowel function and in relation to colorectal car-
cinogenesis in healthy men and women.
Methods
Fibre preparations
Legume kernel fibre preparations from Lupinus
angustifolius cv. Boregine (blue lupin), Lupinus albus cv.
Typ Top (white lupin), and Glycine max cv. Hefeng (soya)
were produced and provided by the Fraunhofer Institute
for Process Engineering and Packaging (Fh-IVV, Freising,
Germany). Legume seeds were cleaned, dehulled and
separated into hulls and kernels by sifting. The kernels
were then flaked and deoiled. Extraction of proteins and
other water-soluble substances from kernels was followed
by pasteurisation. The fibre preparations were then ly-
ophilised and grounded to a fine powder [21,31].
The citrus fibre (Herbacel AQ Plus) provided by
Herbafood (Herbafood Ingredients GmbH, Werder,
Germany) was chosen as active comparator (citrus) due
to its similar composition and comparable properties.
Herbacel AQ Plus is made from de-oiled, dried citrus
fruits. Non-fibrous compounds such as sugars, colouring
and flavouring components are removed during numerous
washing steps. This results in a product with neutral
sensory properties as well as a high water-binding and
retention capacity. The nutrient composition of the fibre
preparations (Table 1) was analysed using the standard
methods according to van Soest et al. [32] and the Associ-
ation of Official Analytical Chemists [33]. All experimental
fibres contained both soluble and insoluble fibre fractions.
The insoluble fibre portion comprised of hemicellulose
and cellulose. The fraction of soluble fibre in both lupin
preparations was markedly higher than in soya or citrus
Table 1 Compositional data of fibre preparations used in the human intervention study
Blue lupin White lupin Soya Citrus
Dry matter [g/100 g FM] 92.5 ± 0.1 90.4 ± 0.2 91.1 ± 0.2 91.1 ± 0.1
Ash [g/100 g DM] 1.67 ± 0.14 1.71 ± 0.05 2.45 ± 0.24 1.34 ± 0.12
Protein [g/100 g DM] 9.68 ± 0.51 12.4 ± 1.1 18.2 ± 0.1 5.31 ± 0.14
Fat [g/100 g DM] 1.12 ± 0.10 1.31 ± 0.12 1.49 ± 0.19 0.31 ± 0.13
Total dietary fibre [g/100 g DM] 86.7 ± 2.1 83.4 ± 2.8 77.3 ± 1.0 92.2 ± 0.2
Soluble dietary fibre [g/100 g DM] 52.6 ± 2.1 50.9 ± 2.8 33.2 ± 1.0 22.5 ± 0.2
Insoluble dietary fibre [g/100 g DM] 34.1 ± 1.5 32.5 ± 2.1 44.1 ± 0.9 69.7 ± 0.3
Hemicellulose [g/100 g DM] 10.9 ± 1.5 16.4 ± 2.1 21.7 ± 0.9 3.70 ± 0.3
Cellulose [g/100 g DM] 23.2 ± 0.9 16.1 ± 1.4 22.4 ± 1.1 65.8 ± 1.2
Lignin [g/100 g DM] 0 0 0 0.22 ± 0.31
Values are presented as mean ± standard deviation.
Blue lupin, Lupinus angustifolius cv. Boregine; white lupin, Lupinus albus cv. Typ Top; soya, Glycine max cv. Hefeng; citrus, citrus fibre Herbacel AQ Plus serving as
active comparator; FM fresh matter, DM dry matter.
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preparations were slightly higher than the value of about
45% previously reported [19,34], which may be associated
to the modified processing method [21,31].
Currently, fibre preparations of lupin, in particular
blue lupin, soya and citrus are used worldwide serving
as functional additive in various food products, including
e.g. bakery, milk and meat products.
Subjects
The study was conducted at the Friedrich Schiller Univer-
sity Jena (Institute of Nutrition, Department of NutritionalAssessed for 
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were recruited for the study by advertising in newspapers
and posting notices on bulletin boards in university insti-
tutes. To be eligible, participants had to be between 20
and 45 years of age, and in good physical health. Exclusion
criteria for all participants included: legume allergy, milk
or lactose intolerance, chronic diseases, pregnancy, lac-
tation, and intake of pharmaceuticals and nutritional sup-
plements. Seventy-eight volunteers fulfilled the selection
criteria and were randomly assigned to three groups via
group matching. Participant flow throughout the trial is
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Figure 2 Study design. BG, blue lupin group; WG, white lupin
group; SG, soya group; blue lupin, Lupinus angustifolius cv. Boregine;
white lupin, Lupinus albus cv. Typ Top; soya, Glycine max cv. Hefeng;
citrus, citrus fibre Herbacel AQ Plus serving as active comparator;
wk, week; DP, dietary protocol (last five days); blood, blood sampling
after overnight fasting (last day); faeces, 3-d collection of faeces (last
three days).
Fechner et al. Nutrition Journal 2013, 12:101 Page 4 of 12
http://www.nutritionj.com/content/12/1/101detailed information regarding purpose, course, and
possible risks involved in the study. A written informed
consent was obtained from all participants. The study was
approved by the Ethical Committee of the Medical Faculty
of the Friedrich Schiller University Jena (1864-09/06). The
consort checklist can be found in Additional file 1.
Study design
The study was designed as a double-blind, controlled,
randomised crossover trial to ensure that each volunteer
served as his or her own control. All persons involved in
the study including scientific staff and study participants
were blinded. In addition, study products were blinded
and labelled using a numeric code. The participants
were randomly divided into three groups: i. the blue
lupin group (BG, n = 26) consumed a fibre preparation
of Lupinus angustifolius cv. Boregine (blue lupin), ii. the
white lupin group (WG, n = 26) received Lupinus albus
cv. Typ Top fibre (white lupin), and iii. the soya group
(SG, n = 26) ingested Glycine max cv. Hefeng fibre
(soya). The conducted study was divided into four
periods, each of two weeks duration: a run-in period,
two intervention periods with supplementation of 25 g
total dietary fibre per day as a legume fibre preparation
or citrus fibre additionally to their usual diet, and a
wash-out period between the intervention periods. At
the beginning of the run-in period, participants were
advised to maintain their lifestyle and nutritional habits
throughout the study. During the run-in and wash-out
periods, each subject included 150 g of a pure milk
product (milk or yoghurt, 3.5% fat) of their own choice
and 150 ml juice (apple, peach, banana, or pear) into
their usual diet to exclude the physiological effects of
these food products from the effects following the fibre
interventions. The participants had to consume the same
type and quantity of these foods during the intervention
periods with added fibre. Throughout the first interven-
tion period, half of the participants from each group re-
ceived one of the legume fibre preparations (blue lupin,
white lupin or soya) and the other half the citrus fibre
(serving as active comparator) for two weeks. Of the
daily fibre dose, half was stirred in the selected milk
product and the other half in juice. After the wash-out
period, intervention with legume fibre and the active
comparator was crossed within each group and the re-
spective fibre preparations were consumed for another
two weeks. At the last five days of run-in period and of
both intervention periods each subject had to record his
or her individual requirements in a dietary protocol to de-
termine their dietary fibre intake. Data were interpreted
using PC-software PRODI® 5.0 expert (NutriScience
GmbH, Freiburg, Germany). During the last three days of
the run-in period and in both intervention periods, a
quantitative faeces collection took place. After defaecation,the samples were transported directly to the institute and
stored at -20°C. Fasting blood samples were drawn on the
last day of each period (Figure 2). In addition, defaecation
discomfort (flatulence, constipation) was assessed in re-
cords during the whole study. At the end of the study,
volunteers had to document their compliance with the
study protocol in an anonymous questionnaire.
The primary outcome of the study was the determin-
ation of LDL cholesterol concentration in serum. Secon-
dary outcomes included estimation of blood lipids, general
excretion parameters, and faecal concentration or excre-
tion of SCFA, neutral sterols, bile acids and fibre.Faecal sample preparation
At the end of each period faecal specimens from all
subjects were defrosted, homogenised, and aliquots
were stored at -20°C. After homogenisation, faecal pH
value was measured using a glass pH electrode (InLab
420 electrode, MP 225; Mettler Toledo GmbH, Giessen,
Germany). One aliquot portion was used for analysis of
SCFA and another one was freeze-dried for determination
of neutral sterols, bile acids, and total food-derived fibre.
For visual assessment of faecal consistency, the ‘Bristol
Stool Form Scale’ (type 1 to 7) was used [35]. The oro-
faecal transit time was determined via marker tablets
containing carmine (E120; C.E. Roeper GmbH, Hamburg,
Germany). After the first defaecation in each period, the
subjects were required to ingest two carmine tablets and
to document the time of intake together with the time of
appearance of the red colour in faeces. The calculation of
the transit time was repeated three times per period.
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The concentrations of total dietary fibre in fibre prepara-
tions and the content of total food-derived fibre in freeze-
dried faeces were determined by standard procedures
recommended by the Association of Official Analytical
Chemists [33] using the enzyme set BIOQUANT® Total
Dietary Fibre (Merck, Darmstadt, Germany) and the filter
machinery FIBERTEC E® described elsewhere [36].
Short-chain fatty acids
Short-chain fatty acid (SCFA) analysis was carried out
via gas chromatography-flame ionisation (Shimadzu-GC
17A; Shimadzu, Kyoto, Japan) using a ZB-FFAP column
(15 m × 0.25 mm × 0.25 μm) as described previously
[37]. After adding distilled water to fresh faeces, samples
were mixed and centrifuged. Subsequently, the super-
natant was added to the internal standard (iso-caproic
acid). Before injection onto the column, the solution was
mixed and centrifuged once more.
Faecal neutral sterols and bile acids
Faecal neutral sterols and bile acids were analysed as
described by Keller and Jahreis [38]. Briefly, aliquots of
lyophilised faeces were transferred into a reaction tube
containing the internal standard 5α-cholestane. The
extraction of sterols was prepared with cyclohexane after
a mild alkaline hydrolysis with ethanolic NaOH. The
solvent was evaporated and extracts were reconstituted
in decane, and injected in the gas chromatography-mass
spectrometer (GC17-QP5000; Shimadzu, Kyoto, Japan)
in duplicate. The total neutral sterol amount was defined
as the sum of cholesterol, coprostanol, coprostanone,
cholestanol and cholestanone. The sum of sterols without
cholesterol was defined as metabolites [39]. The metabolic
conversion rate was calculated as the proportion of total
neutral sterols to metabolites.
For bile acid determination (primary: cholic acid,
chenodeoxycholic acid; secondary: iso-lithocholic acid,
lithocholic acid, iso-deoxycholic acid, deoxycholic
acid, 12-ketodeoxycholic acid), the internal standard
hyodeoxycholic acid was added to the aqueous phase
of sterol extraction. After saponification with NaOH
and acidification to pH 1.0 with HCl, bile acids were
extracted with diethyl ether and evaporated. The residue
was methylated and silylated. Following evaporation, the
residue was dissolved in decane and the solution was
injected into the gas chromatography-mass spectrometer
(GC17-QP5000; Shimadzu, Kyoto, Japan).
Blood lipids
Venous blood samples were taken from subjects after
overnight fasting in serum monovettes. The samples
were centrifuged (2500 × g, 20°C, 15 min) and the
serum supernatant was stored at -80°C until analysis.Serum was analysed for total cholesterol, HDL cholesterol,
and triacylglyceroles using commercially available kits
(Beckmann, Krefeld, Germany) based on enzymatical tests
and employing a fully automated analyser (Synchron LX,
Beckmann Coulter, Fullerton, USA). The concentrations
of LDL cholesterol were calculated using the Friedewald
formula.
Statistical analyses
Prior to the commencement of the study, a power ana-
lysis was performed using PASS 6.0 (NCSS Statistical
Software, Kaysville, UT, USA) to evaluate sample size,
based on data from the literature (LDL cholesterol). It
resulted in a power of > 80% for this study. Samples of
each participant were coded to protect volunteer identity
and to mask treatment groups during the analysis. Statis-
tical calculations were conducted using PASW Statistics
version 18.0 (SPSS Inc., Chicago, IL, USA). Consistent
with the requirement for analysis of variance (ANOVA),
all data were checked for variance homogeneity and for
normal distribution by applying the Levene’s test and the
Kolmogorov-Smirnov test, respectively. To evaluate data
in terms of statistical significance, repeated measures
ANOVA with the general linear model were applied to
identify changes in parameters over time. This model con-
siders both individual and inter-individual changes. The
intervention sequence as a consequence of the crossover
design was considered by pasting the sequence as covari-
ate. No influence of sequence was observed for any of the
analysed parameters. Data that were not normally distrib-
uted were analysed using Wilcoxon signed-rank test to
evaluate changes over time. For each comparison, P ≤ 0.05
was considered as statistically significant. Relationships
between normally distributed variables were examined by
calculating Pearson’s correlation coefficients; otherwise
Spearman (s) correlation was used. Significant differences
between periods are indicated by unequal superscripts. All
results in text and tables are expressed as mean ± standard
deviation.
Results
Initial characteristics, dietary fibre intake and compliance
Study dropout rate was 3% as two subjects (WG) with-
drew from the study during the first week for personal
reasons (Figure 1). Seventy-six volunteers (55 women, 21
men) with a mean age of 24.4 ± 3.2 years (range: 21 - 29 y)
and a mean BMI of 21.7 ± 2.4 kg/m2 (range: 17.2 -
28.9 kg/m2) completed the trial successfully. The initial
characteristics of subjects completing the study are shown
in Table 2.
Consumption of the fibre preparations was well tole-
rated by most of the participants. The general compliance
to the study protocol and the consumption of the
recommended amount of the fibre preparations were
Table 2 Initial characteristics and blood lipids of subjects
BG (n = 26) WG (n = 24) SG (n = 26)
Age [y] 25.6 ± 4.6 24.0 ± 2.2 23.8 ± 1.8
Height [cm] 172 ± 7 172 ± 8 170 ± 10
Weight [kg] 64.7 ± 11.9 66.9 ± 11.7 65.4 ± 10.9
BMI [kg/m2] 21.7 ± 2.5 22.5 ± 2.7 22.4 ± 2.0
Total cholesterol [mmol/L] 4.97 ± 0.93 4.99 ± 1.04 4.54 ± 1.13
HDL cholesterol [mmol/L] 1.64 ± 0.44 1.60 ± 0.40 1.47 ± 0.49
LDL cholesterol [mmol/L] 2.74 ± 0.70 2.78 ± 0.81 2.50 ± 0.69
Triacylglyceroles [mmol/L] 1.12 ± 0.44 1.00 ± 0.41 1.13 ± 0.47
Values are presented as mean ± standard deviation.
BG blue lupin group, WG white lupin group, SG soya group; blue lupin, Lupinus
angustifolius cv. Boregine; white lupin, Lupinus albus cv. Typ Top; soya, Glycine
max cv. Hefeng.
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naires. Thus, the dietary fibre intake throughout the inter-
ventions was additional to their habitual fibre intake,
which changed only slightly. Therefore, the total dietary
fibre intake during all intervention periods was approxi-
mately twice the fibre intake at run-in (42.7 - 46.3 g/d;
P < 0.01; Table 3).
Faecal composition and bowel habits
The lupin fibre supplementations increased the daily fae-
cal dry matter and faecal weight compared to run-in,
representing an increase of 1.76 g faeces/g additional
dietary fibre contributed by blue lupin intervention and
of 1.64 g faeces/g white lupin, respectively (Table 3). The
relative proportion of dry matter in the faeces decreased
significantly due to both lupin fibre interventions. The
effects of soya on the faecal parameters were not signifi-
cant. In all groups, daily faecal mass and faecal dry
matter were significantly higher after intervention withTable 3 Dietary fibre intake, faecal composition and bowel ha
BG (n = 26) WG (n
Run-in Blue lupin Citrus Run-in
Dietary fibre intake [g/d] 22.4 ± 6.4b 45.6 ± 5.8a 46.1 ± 8.7a 18.4 ± 5
Faecal weight [g/d] 132 ± 60b 176 ± 81a 171 ± 107a 103 ± 6
Faecal dry matter
[g/100 g] 27.1 ± 5.1a 24.7 ± 5.3b 24.8 ± 5.0b 28.6 ± 5
[g/d] 34.2 ± 12.6b 40.7 ± 14.1a 38.4 ± 16.9a 28.2 ± 1
Faecal pH 6.65 ± 0.41a 6.38 ± 0.47b 6.49 ± 0.52ab 6.51 ± 0
Transit time [d]1 1.29 ± 0.61b 1.02 ± 0.33c 1.48 ± 0.72a 1.47 ± 0
Bristol Stool Form Scale 3.32 ± 1.04b 3.71 ± 0.80b 3.79 ± 0.92a 3.64 ± 1
Total faecal fibre [g/d] 10.3 ± 4.5b 13.3 ± 5.5a 13.8 ± 9.3a 7.59 ± 3
Values are presented as mean ± standard deviation.
BG blue lupin group; WG white lupin group; SG soya group; blue lupin, Lupinus ang
cv. Hefeng; citrus, citrus fibre Herbacel AQ Plus serving as active comparator.
a>b>cSignificant differences between mean values within each group with unequal s
1Oro-faecal transit time: BG (n = 24), WG (n = 20), SG (n = 20).citrus fibre compared to run-in but were not signifi-
cantly different amongst the fibre supplementations
within the groups. The relative proportion of dry matter
decreased significantly due to citrus intervention, except
in SG. Faecal pH value was found to decrease signifi-
cantly in the blue lupin period compared to run-in (0.27
units, P < 0.01), but did not change compared to citrus.
However, no significant differences between the study
periods were seen in WG or SG. In BG, the oro-faecal
transit time differed significantly between run-in and
both fibre periods. Furthermore, as evaluated by the
‘Bristol Stool Form Scale’, appearance of faeces was
significantly affected throughout the fibre interventions.
In comparison to run-in, all fibre supplementations led
to significantly higher stool form scores, which is equiva-
lent to a looser and more watery faecal consistency. The
appearance of faeces did not differ between fibre inter-
ventions within the groups.
For both interventions with lupin fibre, a significant
enhancement of faecal excretion of total food-derived
fibre was observed. In all groups, the consumption of
citrus fibre resulted in a significantly higher faecal content
of total food-derived fibre compared to run-in.
Short-chain fatty acids
Both types of lupin interventions led to an enhanced for-
mation of SCFA whereby total daily SCFA excretion as
well as excretion of the main SCFA acetate, propionate,
and n-butyrate increased significantly compared to run-
in. No significant differences between the molar ratios
(% of total) of the main SCFA during fibre interventions
and run-in were observed in any group. Concerning the
faecal concentrations of total SCFA, only blue lupin
showed a significant enhancement compared to both the
run-in (20%, P = 0.02) and citrus period (16%, P = 0.03).bits
= 24) SG (n = 26)
White lupin Citrus Run-in Soya Citrus
.0b 42.7 ± 6.1a 43.3 ± 5.1a 21.8 ± 5.7b 46.3 ± 5.3a 45.3 ± 5.5a
2b 144 ± 81a 142 ±65a 135 ± 63b 156 ±73ab 173 ± 70a
.8a 26.0 ± 5.3b 25.1 ± 4.4b 26.1 ± 5.0 25.6 ± 5.1 24.9 ± 4.7
2.4b 35.7 ± 17.3a 35.0 ± 13.3a 33.6 ± 13.3b 38.2 ± 15.2ab 42.9 ± 18.9a
.33 6.54 ± 0.40 6.46 ± 0.40 6.42 ± 0.34 6.45 ± 0.30 6.45 ± 0.56
.7 1.39 ± 0.57 1.28 ± 0.49 1.28 ± 0.61 1.33 ± 0.64 1.31 ± 0.42
.04b 4.18 ± 1.14a 4.30 ± 1.01a 3.56 ± 1.13b 4.18 ± 1.21a 4.15 ± 0.78a
.73b 9.77 ± 4.85a 9.98 ± 4.3a 9.63 ± 3.79b 11.4 ± 4.4ab 13.5 ± 8.7a
ustifolius cv. Boregine; white lupin, Lupinus albus cv. Typ Top; soya, Glycine max
uperscript letters (P ≤ 0.05) determined by repeated measures ANOVA.
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propionate were significantly increased compared to
run-in. In comparison to citrus, the concentrations of
propionate and n-butyrate were significantly higher after
blue lupin. With regard to the faecal concentrations of
the three main SCFA, no significant changes were ob-
served following consumption of citrus fibre compared
to run-in. All fibre interventions, particularly the citrus
fibre, resulted in lower concentrations of iso-butyric acid
and iso-valeric acid (Table 4).
Neutral sterols and bile acids
Low converter revealed a high cholesterol excretion
together with a very low excretion of the microbial
transformation product coprostanol. The reasons and
outcomes of this phenomenon have not been suffi-
ciently investigated because of the complexity of the
host-microflora interactions [39]. Hence, the data were
statistically analysed using the values after excluding
low converters. A cholesterol conversion of ≤ 25% was
defined as a cut-off level for classification as low
converter. Eighteen participants (blue lupin: n = 7; white
lupin: n = 3; soya: n = 8) showed this altered neutral
sterol profile in at least one study period and were
defined as low converters. After exclusion of lowTable 4 Concentration and daily excretion of short-chain fatt
BG (n = 26) WG (n = 24)
Run-in Blue lupin Citrus Run-in
Faecal concentration [μmol/g faeces]
Total SCFA 62.9 ± 23.3b 75.4 ± 24.0a 65.3 ± 24.2b 69.4 ± 23.0
Acetate 37.3 ± 13.1b 45.6 ± 12.3a 41.2 ± 15.9ab 41.5 ± 12.8
Propionate 9.86 ± 4.73b 11.9 ± 5.0a 9.05 ± 3.89b 10.7 ± 5.3
iso-Butyrate 1.11 ± 0.45 0.97 ± 0.55 0.91 ± 0.49 1.49 ± 0.59a
n-Butyrate 11.4 ± 6.5ab 14.0 ± 8.4a 11.3 ± 6.4b 11.0 ± 5.3
iso-Valerat 1.76 ± 0.70a 1.46 ± 0.78b 1.47 ± 0.79b 2.14 ± 0.89a
n-Valerat 1.17 ± 0.57 1.18 ± 0.60 0.98 ± 0.53 1.54 ± 0.72
n-CaproateW 0.26 ± 0.44b 0.30 ± 0.42ab 0.39 ± 0.50a 0.52 ± 0.67b
Daily excretion [mmol/d]
Total SCFA 8.89 ± 6.30b 14.1 ± 9.5a 12.0 ± 10.0a 7.68 ± 5.78b
Acetate 5.20 ± 3.53b 8.57 ± 5.95a 7.49 ± 6.18a 4.61 ± 3.49b
Propionate 1.44 ± 1.20b 2.25 ± 1.61a 1.75 ± 1.70b 1.25 ± 1.08b
iso-Butyrate 0.15 ± 0.08 0.15 ± 0.09 0.13 ± 0.08 0.14 ± 0.07
n-Butyrate 1.69 ± 1.45b 2.71 ± 2.35a 2.24 ± 2.21a 1.27 ± 1.15b
iso-Valerat 0.22 ± 0.11 0.22 ± 0.12 0.20 ± 0.10 0.20 ± 0.10
n-Valerat 0.16 ± 0.13 0.19 ± 0.13 0.16 ± 0.13 0.16 ± 0.10
n-CaproateW 0.04 ± 0.08b 0.04 ± 0.06ab 0.05 ± 0.09a 0.05 ± 0.07b
Values are presented as mean ± standard deviation.
BG blue lupin group, WG white lupin group, SG soya group; blue lupin, Lupinus ang
cv. Hefeng; citrus, citrus fibre Herbacel AQ Plus serving as active comparator.
a>b>cSignificant differences between mean values within each group with unequal s
WValues were not normally distributed; significance was calculated by means of theconverters, the average daily excretion of neutral sterols
remained constant over the entire study course (data
not shown). However, the concentration of total sterols,
coprostanol, and coprostanone in the dry faeces in-
creased significantly under the blue lupin fibre-regimen
compared to run-in (Table 5). Following citrus, the
faecal concentration of coprostanone decreased signifi-
cantly in white lupin compared to run-in.
In the faeces, blue lupin fibre intervention significantly
increased the daily excretion of the sum of primary bile
acids (18.2 ± 12.1 vs. 27.9 ± 22.5 mg/d, P = 0.02) as well as
cholic acid (9.26 ± 5.46 vs. 14.6 ± 12.0 mg/d, P = 0.02) and
chenodeoxycholic acid (8.98 ± 7.32 vs. 13.3 ± 11.1 mg/d,
P = 0.03) compared to run-in. The other fibre interven-
tions did not alter excretion of bile acids (data not shown).
All three interventions with legume fibre reduced the
concentration of total bile acids (blue lupin: 14%, P = 0.05;
white lupin: 21%, P < 0.01; soya: 17%, P = 0.04) and the
sum of secondary bile acids (blue lupin: 16%, P = 0.03;
white lupin: 24%, P < 0.01; soya: 16%, P = 0.06) in dry
faeces. Due to supplementation with citrus fibre, the
concentration of total bile acids (mean: 22%, P < 0.03) and
secondary bile acids (mean: 23%, P < 0.03) decreased signifi-
cantly in comparison to run-in in all groups. The changes
in the concentrations can mainly be ascribed to they acids (SCFA) in faeces
SG (n = 26)
White lupin Citrus Run-in Soya Citrus
75.0 ± 21.4 72.4 ± 22.6 77.1 ± 21.1 81.3 ± 19.7 75.7 ± 23.5
45.9 ± 12.5 45.0 ± 13.6 46.5 ± 12.4 49.6 ± 12.7 46.1 ± 14.4
11.9 ± 4.6 10.3 ± 4.3 13.2 ± 6.6ab 15.0 ± 4.9a 12.2 ± 5.5b
1.25 ± 0.51b 1.15 ± 0.52b 1.25 ± 0.56a 1.21 ± 0.63a 0.95 ± 0.38b
12.3 ± 6.3 11.9 ± 5.4 12.6 ± 5.1 12.1 ± 4.4 13.3 ± 6.3
1.69 ± 0.90b 1.57 ± 0.77b 1.70 ± 0.88a 1.58 ± 1.02ab 1.28 ± 0.58b
1.41 ± 0.58 1.40 ± 0.61 1.29 ± 0.73 1.21 ± 0.78 1.14 ± 0.67
0.60 ± 0.57ab 0.99 ± 1.24a 0.58 ± 0.74 0.58 ± 0.77 0.66 ± 078
11.7 ± 9.1a 10.9 ± 7.2a 11.0 ± 6.8 12.9 ± 7.1 12.9 ± 6.5
7.09 ± 5.50a 6.68 ± 4.10a 6.63 ± 4.23 7.96 ± 4.61 7.86 ± 4.13
1.84 ± 1.47a 1.61 ± 1.38ab 1.91 ± 1.47 2.35 ± 1.25 2.11 ± 1.22
0.16 ± 0.09 0.16 ± 0.11 0.16 ± 0.09 0.17 ± 0.10 0.16 ± 0.08
2.09 ± 2.01a 1.89 ± 1.48a 1.80 ± 1.28b 1.90 ± 1.24b 2.28 ± 1.48a
0.21 ± 0.12 0.21 ± 0.13 0.21 ± 0.12 0.21 ± 0.11 0.21 ± 0.10
0.19 ± 0.11 0.20 ± 0.15 0.18 ± 0.13 0.18 ± 0.14 0.19 ± 0.13
0.08 ± 0.10ab 0.15 ± 0.22a 0.08 ± 0.11b 0.09 ± 0.13ab 0.11 ± 0.15a
ustifolius cv. Boregine; white lupin, Lupinus albus cv. Typ Top; soya, Glycine max
uperscript letters (P ≤ 0.05) determined by repeated measures ANOVA.
Wilcoxon test.
Table 5 Concentration of neutral sterols and bile acids in dry faeces
Faecal neutral sterol concentration [mg/g dry faeces]
BG (n = 19) WG (n = 21) SG (n = 18)
Run-in Blue lupin Citrus Run-in White
lupin
Citrus Run-in Soya Citrus
Total NS 21.6 ± 8.1a 18.3 ± 5.3b 19.8 ± 6.6ab 22.8 ± 5.8 22.2 ± 6.3 20.8 ± 5.6 19.8 ± 5.8 18.7 ± 5.0 18.3 ± 5.4
Cholesterol 2.87 ± 1.82 2.56 ± 1.11 2.63 ± 1.67 2.54 ± 1.38 2.76 ± 1.53 2.98 ± 2.19 2.80 ± 2.30 2.19 ± 0.92 3.09 ± 1.62
Coprostanol 16.0 ± 6.5a 13.4 ± 4.6b 14.9 ± 5.5ab 16.8 ± 5.1 16.5 ± 5.7 15.3 ± 5.4 14.3 ± 5.3 14.2 ± 5.0 13.0 ± 5.0
Cholestanol 0.64 ± 0.11 0.64 ± 0.12 0.62 ± 0.15 0.56 ± 0.16 0.60 ± 0.08 0.59 ± 0.07 0.61 ± 0.10 0.61 ± 0.14 0.60 ± 0.12
Coprostanone 1.85 ±
1.32a




1.94 ± 1.23ab 1.57 ± 0.85b 1.67 ± 0.88 1.31 ± 0.75 1.26 ± 0.62
Cholestanone 0.04 ± 0.06 0.05 ± 0.05 0.05 ± 0.06 0.14 ± 0.03 0.14 ± 0.06 0.13 ± 0.03 0.10 ± 0.03 0.11 ± 0.02 0.11 ± 0.04
Cholestenone 0.24 ± 0.14 0.20 ± 0.11 0.22 ± 0.11 0.30 ± 0.08 0.27 ± 0.07 0.30 ± 0.12 0.26 ± 0.09 0.24 ± 0.07 0.27 ± 0.11
Faecal bile acid concentration [mg/g dry faeces]
BG (n = 26) WG (n = 24) SG (n = 25)
Run-in Blue lupin Citrus Run-in White
lupin
Citrus Run-in Soya Citrus
Total BA 6.97 ±
2.72a
6.03 ± 2.17a 5.07 ± 1.82b 6.86 ±
1.86a
5.45 ± 1.73b 5.27 ± 1.95b 6.40 ±
2.39a
5.33 ± 2.49b 5.39 ± 2.28b
Primary BA 0.53 ± 0.27 0.66 ± 0.46 0.51 ± 0.29 0.53 ± 0.34 0.62 ± 0.61 0.42 ± 0.15 0.57 ±
0.28a
0.44 ± 0.22b 0.51 ±
0.30ab
Cholic acid 0.28 ± 0.15 0.35 ± 0.25 0.26 ± 0.15 0.28 ± 0.16 0.36 ± 0.41 0.24 ± 0.13 0.28 ±
0.12a
0.22 ± 0.11b 0.26 ±
0.17ab
Chenodeoxycholic acid 0.26 ± 0.14 0.31 ± 0.23 0.24 ± 0.16 0.25 ± 0.27 0.25 ± 0.22 0.18 ± 0.07 0.30 ±
0.18a
0.22 ± 0.13b 0.25 ±
0.14ab
Secondary BA 6.43 ±
2.68a
5.36 ± 2.17b 4.57 ± 1.69b 6.33 ±
1.77a





Iso-lithocholic acid 1.15 ±
0.56a
0.96 ± 0.44b 0.91 ± 0.48b 0.99 ±
0.42a
0.80 ± 0.46b 0.88 ±
0.51ab
1.00 ± 0.47 1.02 ± 0.50 0.90 ± 0.55
Lithocholic acid 1.57 ±
0.79a
1.27 ± 0.69b 1.06 ± 0.53c 1.45 ±
0.51a
1.12 ± 0.36b 1.03 ± 0.37b 1.38 ±
0.58a
1.08 ± 0.51b 1.07 ± 0.47b




0.78 ± 0.42b 1.10 ±
0.67a
0.86 ± 0.64b 0.93 ±
0.74ab
1.13 ± 0.56 1.12 ± 0.76 1.03 ± 0.66
Deoxycholic acid 2.43 ±
1.30a
2.03 ± 0.95a 1.65 ± 0.88b 2.53 ±
1.03a
1.89 ± 0.97b 1.85 ± 0.87b 2.13 ±
1.12a







0.17 ± 0.09b 0.26 ±
0.24a
0.16 ± 0.06b 0.16 ± 0.06b 0.19 ± 0.07 0.16 ± 0.07 0.18 ± 0.09
Values are presented as mean ± standard deviation.
BG blue lupin group, WG white lupin group, SG soya group; blue lupin, Lupinus angustifolius cv. Boregine; white lupin, Lupinus albus cv. Typ Top; soya, Glycine max
cv. Hefeng; citrus, citrus fibre Herbacel AQ Plus serving as active comparator; NS neutral sterols, BA bile acids.
a>b>cSignificant differences between mean values within each group with unequal superscript letters (P ≤ 0.05) determined by repeated measures ANOVA.
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(Table 5). Soya was the only fibre that decreased the
sum of primary bile acids (23%, P = 0.04) as well as
cholic acid (21%, P = 0.04) and chenodeoxycholic acid
(27%, P = 0.04) in dry faeces.
Blood lipids
Total cholesterol, HDL cholesterol, LDL cholesterol, and
triacylglycerol concentrations in serum were not
influenced by any of the interventions (data not shown).
All values determined from the participants were within
the normal range (total cholesterol: 4.84 ± 1.04 mmol/L;
HDL cholesterol: 1.57 ± 0.44 mmol/L; LDL cholesterol:2.67 ± 0.73 mmol/L; triacylglyceroles: 1.09 ± 0.44 mmol/L;
Table 1).
Discussion
Administration of the tested lupin and citrus fibre at a
dose of 25 g/day for two weeks resulted in an increase in
daily faecal mass and faecal dry matter. Increased faecal
bulking and, therefore, dilution of carcinogens is one of
the proposed mechanisms by which dietary fibre reduce
the risk of colorectal cancer [16,24]. In contrast to the
lupin interventions, the effects of soya intervention on
faecal mass and faecal excretion of total food-derived
fibre were not significant. Other studies detected more
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http://www.nutritionj.com/content/12/1/101distinct effects for soya fibre regarding faecal bulking
[18]. Because both lupin fibres contain less quantities of
water-insoluble fibre than soya, fermentable fibre frac-
tions must be responsible for the enhanced faecal mass
due to a gain in bacterial mass. Moreover, lupin kernel
fibre is characterised by a higher water-binding capacity
[20,40]. A daily faecal mass > 150 g/d is supposed to
lower the risk of colorectal cancer [24]. We observed
that consumption of blue lupin and soya, as well as
citrus in these respective groups, resulted in an increase
in mean faecal weight above this low-risk cut-off value.
The higher gut content stimulates intestinal peristalsis
reducing the oro-faecal transit time [15,24]. In the
present study, the supplementation with blue lupin led
to the highest increase in faecal weight (33%, P < 0.01)
and shortened the oro-faecal transit time significantly by
21% (P = 0.04). Moreover, subjects with a long transit
time, especially participants suffering from constipation,
reported an increased frequency of defaecation and an
improved ease of defaecation confirmed by a meliorated
faecal consistency. The obtained results are in line with
the findings of a study investigating the effects of a high-
fibre diet containing lupin kernel fibre (L. angustifolius)
by Johnson et al. [19]. The intake of 17 - 30 g/d lupin
kernel fibre for four weeks led to an increase of 21% in
faecal output and resulted in a 17% decline in transit
time [19].
In the current study, all tested fibre interventions led
to an enhanced excretion of total SCFA as well as the
main SCFA acetate, propionate, and n-butyrate (Table 4).
However, a significant increase could only be shown as a
consequence of intervention with both lupin fibres,
which contain a higher content of water soluble fibre
than soya and citrus fibre. The study by Johnson et al.
provided the first evidence that lupin kernel fibre modi-
fies levels of faecal SCFA [19]. The present data revealed
that SCFA concentration was not affected to a large
extent because the SCFA formed were diluted due to the
increased faecal mass. SCFA, particularly n-butyrate, areBlue lupin con
Improved stool consistency; ↑ Faecal mass
↓ Oro-faecal transit time
↓ Exposure of colonocytes to
↓ Risk of colo
↓ Concentration of sec
Water binding
Figure 3 Schematic summary of the physiological effects of blue lupinan important energy source for colonocytes. In addition,
n-butyrate is able to reduce the risk of malignant
changes through regulation of colonocyte differentiation
[25,41,42]. Due to the enhanced SCFA formation, both
lupin fibre interventions could elevate n-butyrate excre-
tion significantly (blue lupin: 60%, P < 0.01; white lupin:
65%, P < 0.01) and the faecal concentration slightly (blue
lupin: 23%, P = 0.11; white lupin: 12%, P = 0.18). In-
creased SCFA concentration lowers the pH value, which
consequently decreases the formation of carcinogenic
substances [24,27]. A significant negative correlation
(r = -0.58(s), P < 0.01) of SCFA excretion and faecal pH
confirms the influence of SCFA on pH value in colon
and faeces. In the present study, a significantly lower
faecal pH was observed after blue lupin intervention.
The reduction in the faecal pH values after blue lupin
was of equal magnitude to that previously observed for
lupin kernel fibre diet [19]. Despite the observed
changes in SCFA excretion after white lupin interven-
tion, faecal pH was not reduced (Table 3).
All types of fibre used in this study had no effect on
the daily excretion of neutral steroids which is similar to
results obtained from previous studies of other types of
dietary fibre [15]. The concentrations of total neutral
sterols, coprostanol, and coprostanone decreased after
intervention with blue lupin as a result of the dilution
effect due to the increased faecal mass.
Only blue lupin increased the faecal excretion of pri-
mary bile acids, whereas the average excretion of total
bile acids remained unchanged. It appears that contrary
to what is reported in the literature and demonstrated
in vitro [31], bile acids were not bound by the fibre prep-
arations. In fact, the decrease in the pH value seems to
be responsible for the increased excretion of primary bile
acids. A pH value < 6.5 (blue lupin: 6.38) inhibits the
activity of 7 α-dehydroxylase, which is involved in the
conversion of bile acids and enhances the precipitation
of bile acids [4]. Moreover, all fibre interventions
lowered the faecal concentration of bile acids (Table 5).sumption
 potential carcinogens
Promotion of bacterial growth
n cancer
↑ SCFA formation (e.g. n-butyrate)
↓ pH value
ondary bile acids
fibre in the colon [21]. blue lupin, Lupinus angustifolius cv. Boregine.
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this decrease in concentration is due to the increase of
daily faecal mass or dry matter and the altered pH value.
Acid steroids, particularly the secondary bile acids, are
potential risk factors for colorectal cancer [22,28,29].
Indeed, various studies have shown that bile acids play
an etiologic role in colorectal cancer by causing DNA
damage. Numerous epidemiological studies support the
hypothesis that incidence of colorectal cancer correlates
with faecal bile acid levels [28]. Furthermore, the modified
milieu in the colon might restrict growth of potential
pathogens as well as putrefactive bacteria. A study in 18
male subjects ingesting 17–30 g/d lupin kernel fibre incor-
porated in food for a period of 28 days revealed that lupin
kernel fibre may be considered as prebiotic since colonic
bifidobacteria growth was found stimulated [43].
A deficit of bile acids in the enterohepatic circulation
should lead to a compensatory synthesis of new bile
acids from cholesterol in the liver which, in turn, results
lower blood cholesterol concentrations [30]. As men-
tioned above, bile acid-binding was not detected in the
present study, because the fibre interventions did not
alter the excretion of total bile acids. In line with this,
blood cholesterol levels remained unaffected. In contrast
to our results, one study, which focused on foods
enriched with lupin kernel fibre, revealed that additional
consumption of 17 - 30 g/d lupin fibre for one month
resulted in significant reductions of total and LDL
cholesterol compared to the controlled diet. Hall et al.
underlined that the cholesterol-lowering effect was re-
stricted to hypercholesterolaemic subjects [34]. In an-
other study of our work group in hypercholesterolaemic
subjects, a four-week intervention with 25 g/d blue lupin
incorporated in food led also to a decrease of total and
LDL cholesterol, in spite of unchanged bile acid excretion
[21]. Hence, the below average cholesterol concentration
in the present study (Table 2) may explain the lack of
effect of the tested fibre preparations on blood lipids.
Conclusions
The findings of the present study confirm that dietary
fibre from different plant sources often demonstrate
unique physiological effects in the gut, which is in line
with the inconsistent data achieved from a number of
studies investigating an association between dietary fibre
consumption and occurrence of colorectal cancer. In
addition, other aspects such as fat content in the diet, con-
sumption of red meat, and presence of micronutrients
may also play a role in the development of colorectal can-
cer. Hence, randomised controlled intervention studies
are not able to directly establish the effects of an increased
dietary fibre intake on the development of colorectal
cancer [44]. In line with this, a Cochrane meta-analysis of
five randomised controlled trials (in a total of 4349subjects) of increased dietary fibre intake to prevent recur-
rence of adenomatous polyps, as surrogate endpoint,
found no difference between intervention and control
groups with regard to the development of adenomas [45].
Nevertheless, the randomised controlled trial selected for
the current analysis is the most appropriate study design
to investigate specific types of fibres as well as to interpret
and compare their individual effects, at least for the
respective study population.
Results obtained in the present study show that a daily
intake of 25 g legume kernel fibre or citrus fibre over
two weeks failed to affect lipid metabolism through bile
acid-binding in healthy, normocholesterolaemic subjects.
However, the obtained findings suggest that all tested
fibre preparations might be able to prevent constipation
as they improve faecal consistency and oro-faecal transit
time and therefore exert a positive impact on colonic
function. The fibre preparations of legumes, particularly
Lupinus angustifolius cv. Boregine additionally have bene-
ficial effects on putative risk factors for colorectal cancer
such as daily faecal mass, oro-faecal transit time, SCFA
production, pH value, and concentration of secondary bile
acids (Figure 3).
Overall, it can be concluded that increasing dietary
fibre intake of blue lupin kernel fibre in the range of
about 50 g/d may in general and, in particular, in
predisposed people contribute towards the prevention of
colorectal cancer and support medical therapies.
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